METTL3 and hepatocellular carcinoma: METTL3 mediates lncRNA mitogen-activated protein kinase activation of protein kinase five antisense RNA 1 (MAAS) targeting c-Myc to promote the proliferation of HBV + HCC cells (Tao et al., 2022).